Description

Alvobak (ceftriaxone) powder for solution for injections 1g. №1 vial

Ingredients:

Each vial contains 1g of ceftriaxone sodium.

Dosage:

The dosage and duration of therapy should be determined by a healthcare provider. Alvobak is typically administered intravenously or intramuscularly once or twice daily.

Indications:

Alvobak is indicated for the treatment of various bacterial infections, including respiratory tract infections, skin and soft tissue infections, urinary tract infections, and more.

Contraindications:

Do not use Alvobak if you have a known allergy to ceftriaxone or other cephalosporins. It is important to discuss any allergies with your healthcare provider before starting treatment.

Directions:

Alvobak should be reconstituted with the appropriate diluent as directed by a healthcare professional. The solution should be clear and free from particles before administration.

Scientific Evidence:

Studies have shown the efficacy of ceftriaxone in treating a wide range of bacterial infections. Research published in the Journal of Antimicrobial Chemotherapy demonstrated the effectiveness of ceftriaxone in treating severe infections.

Additional Information:

It is important to complete the full course of Alvobak as prescribed by your healthcare provider. Failure to do so may result in the infection not being fully treated and could lead to antibiotic resistance.

Pharmacological Effects: Ceftriaxone, the active ingredient in Alvobak, works by inhibiting bacterial cell wall synthesis, leading to the death of the bacteria. It has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria.

Clinical Trials: Clinical trials have demonstrated the efficacy of ceftriaxone in various infections, showing high rates of success and low incidence of adverse effects. A study published in Clinical Infectious Diseases highlighted the effectiveness of ceftriaxone in treating complicated urinary tract infections.